The evaluation of cost-effectiveness and cost-utility of valganciclovir for the prophylaxis of cytomegalovirus disease to 200 days after kidney transplantation

Authors
Publication date
1 January 2013
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Jagiellonian Univeristy Repository

    redirect
    oaioai:ruj.uj.edu.pl:item/131582
    Last time updated on 21/01/2020